CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Revenues
Total revenues	$ 8,598,776	$ 6,651,290	$ 16,819,415	$ 12,930,718
Cost of revenues	3,900,965	3,498,723	7,123,355	6,946,345
Gross profit	4,697,811	3,152,567	9,696,060	5,984,373
Operating expenses
Selling, general and administrative	4,255,976	3,474,562	8,896,888	7,339,548
Depreciation and amortization	713,180	614,182	1,392,351	1,210,030
Total operating expenses	4,969,156	4,088,744	10,289,239	8,549,578
Loss from operations	(271,345)	(936,177)	(593,179)	(2,565,205)
Other income
Interest income, net	70,227	5,010	84,563	12,111
Loss before income tax provision	(201,118)	(931,167)	(508,616)	(2,553,094)
Income tax provision	26,916	800	28,813	2,400
Net loss	$ (228,034)	$ (931,967)	$ (537,429)	$ (2,555,494)
Net loss per share
Basic	$ (0.00)	$ (0.02)	$ (0.01)	$ (0.05)
Diluted	$ (0.00)	$ (0.02)	$ (0.01)	$ (0.05)
Weighted average common shares
Basic	51,993,031	50,748,437	51,906,335	50,551,299
Diluted	51,993,031	50,748,437	51,906,335	50,551,299
Plasma Industry [Member]
Revenues
Total revenues	$ 7,806,201	$ 5,947,313	$ 15,200,565	$ 11,330,464
Pharmaceutical industry [Member]
Revenues
Total revenues	773,311	641,037	1,579,879	1,523,867
Other Revenue [Member]
Revenues
Total revenues	$ 19,264	$ 62,940	$ 38,971	$ 76,387